An antibiotic commonly prescribed for bronchitis and sinus infections may increase the risk of death from heart problems, but only for people with certain risk factors, a new study suggests. The study ...

Taking azithromycin for as little as one day triggers antibiotic resistance in the respiratory tract, according to a first-of ...

At IDWeek, 2025, held on 19–22 October, Dr Sarah McLeod from Innoviva Specialty Therapeutics presented subgroup analyses from a global Phase III noninferiority randomised controlled trial which ...

Mass administration of azithromycin to both infants aged 1-11 months and children aged 12-59 months reduced infant mortality compared with treating infants alone. Although the interaction effect was ...

Findings showed zoliflodacin was noninferior to ceftriaxone plus azithromycin (microbiological cure rate, 90.9% vs 96.2%, respectively; difference, 5.3%). The Food and Drug Administration (FDA) has ...